Masaya Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 11-12-2024
- Paid Up Capital ₹ 1.00 Cr
as on 11-12-2024
- Company Age 3 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 217.59%
(FY 2023)
- Profit 107.17%
(FY 2023)
- Ebitda -225.02%
(FY 2023)
- Net Worth 1936.19%
(FY 2023)
- Total Assets 60.06%
(FY 2023)
About Masaya Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Debashis Haldar and Animesh Mallick serve as directors at the Company.
- CIN/LLPIN
U24230WB2021PTC243850
- Company No.
243850
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Mar 2021
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Masaya Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Debashis Haldar  | Director | 15-Mar-2021 | Current |
| Animesh Mallick | Director | 15-Mar-2021 | Current |
Financial Performance of Masaya Pharmaceuticals.
Masaya Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 217.59% increase. The company also saw a substantial improvement in profitability, with a 107.17% increase in profit. The company's net worth Soared by an impressive increase of 1936.19%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Masaya Pharmaceuticals?
In 2023, Masaya Pharmaceuticals had a public holding of 17.10%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Masaya Pharmaceuticals?
Masaya Pharmaceuticals has a workforce of 73 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Masaya Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Masaya Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
